西南医科大学学报2024，Vol.47Issue(1)：87-92,6.DOI:10.3969/j.issn.2096-3351.2024.01.017
选择性COX-2抑制剂引起心血管风险的研究进展
Research progress on cardiovascular risks induced by selective COX-2 inhibitors
摘要
Abstract
[Absract]Non-steroidal anti-inflammatory drugs(NSAIDs)are effective and widely used anti-inflammatory and analgesic drugs,and their inhibitory effects on cyclooxygenase(COX)will cause different reactions.Selective COX-2 inhibitors will significantly increase the risk of adverse cardiovascular events.With the increasing use of such drugs and the accumulation of clinical evidence,the cardiovascular risks they bring have attracted more and more attention from scholars.This review highlighted resent research of cardio-vascular risks caused by selective COX-2 inhibitors and provided evidences for rational drug use in clinical practice.关键词
非甾体类抗炎药/环氧合酶/选择性环氧合酶-2抑制剂/心血管风险Key words
Non-steroidal anti-inflammatory drug/Cyclooxygenase/Selective COX-2 inhibitors/Cardiovascular risk分类
医药卫生引用本文复制引用
黄勇,李頔,王娜,冉娅娟,雷筱梅,钱妍..选择性COX-2抑制剂引起心血管风险的研究进展[J].西南医科大学学报,2024,47(1):87-92,6.基金项目
重庆市卫生适宜技术推广项目(2022jstg022) （2022jstg022）
